Inteliview

KR ETFRISE· 253280

RISE 헬스케어

Issuer: KB자산운용

1Y Return

20.6%

YTD Return

-4.6%

3Y CAGR

21.6%

5Y CAGR

21.6%

1Y Volatility

35.4%

1Y Sharpe

0.48

Max Drawdown

-17.0%

Close

KRW 16330

Profile

Asset class: equity

Region: KR

Currency exposure: native

Monthly dividend: No

Leveraged: No

Pension-eligible: Yes

ISA-eligible: Yes

Themes

섹터/테마

Top 30 Holdings · KIS Open API

Official Korea Investment & Securities Open API. As of 2026-05-08.

01셀트리온06827011.42%—

02삼성바이오로직스2079409.39%—

03HLB0283008.36%—

04알테오젠1961708.08%—

05삼천당제약0002506.86%—

06에이비엘바이오2983806.64%—

07리가켐바이오1410805.99%—

08유한양행0001005.89%—

09한미약품1289403.34%—

10SK바이오팜3260303.31%—

11파마리서치2144502.79%—

12에스티팜2376902.47%—

13한올바이오파마0094201.90%—

14휴젤1450201.90%—

15클래시스2141501.46%—

16SK바이오사이언스3024401.37%—

17셀트리온제약0687601.35%—

18파미셀0056901.32%—

19엘앤씨바이오2906501.25%—

20차바이오텍0856601.04%—

21오름테라퓨틱4758300.96%—

22씨젠0965300.96%—

23녹십자0062800.93%—

24한미사이언스0089300.92%—

25HK이노엔1959400.87%—

26종근당1857500.80%—

27대웅제약0696200.80%—

28메디톡스0869000.69%—

29동국제약0864500.67%—

30일동제약2494200.60%—

N gurus = the number of Wall Street gurus (Buffett, Dalio, etc.) holding the same ticker per their latest 13F filings. Click through to see the full guru list on the asset detail page.

Distribution history — Phase 2

Will appear once SEIBro distribution data is loaded.

Gurus holding this ETF — Phase 4

Will appear once 13F holdings data is joined in.

Metrics as of 2026-05-05 · Last close 2026-05-05